Published in Transfus Med Hemother on July 04, 2013
Anti-inflammatory activity of intravenous immunoglobulins protects against West Nile virus encephalitis. J Gen Virol (2015) 0.79
Implementation of NAT Screening for West Nile Virus and Experience with Seasonal Testing in Germany. Transfus Med Hemother (2015) 0.78
Zika Virus (ZIKV). Transfus Med Hemother (2016) 0.75
West Nile Virus in Europe and Safety of Blood Transfusion. Transfus Med Hemother (2016) 0.75
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol (1999) 13.55
West Nile virus. Lancet Infect Dis (2002) 7.97
Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis (2003) 7.96
West Nile encephalitis epidemic in southeastern Romania. Lancet (1998) 7.73
West Nile fever--a reemerging mosquito-borne viral disease in Europe. Emerg Infect Dis (1999) 7.50
Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis (2005) 6.09
A structural perspective of the flavivirus life cycle. Nat Rev Microbiol (2005) 5.02
Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med (2003) 4.95
An update on the potential of north American mosquitoes (Diptera: Culicidae) to transmit West Nile Virus. J Med Entomol (2005) 4.13
Proteolytic activation of tick-borne encephalitis virus by furin. J Virol (1997) 3.78
West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu Rev Med (2006) 3.68
CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med (2006) 3.57
Structure of West Nile virus. Science (2003) 3.48
Persistent infection with West Nile virus years after initial infection. J Infect Dis (2010) 3.33
Effects of temperature on the transmission of west nile virus by Culex tarsalis (Diptera: Culicidae). J Med Entomol (2006) 3.19
Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases. Emerg Infect Dis (2003) 3.17
West Nile outbreak in horses in southern France, 2000: the return after 35 years. Emerg Infect Dis (2001) 3.16
Emergence of Usutu virus, an African mosquito-borne flavivirus of the Japanese encephalitis virus group, central Europe. Emerg Infect Dis (2002) 2.88
Temperature, viral genetics, and the transmission of West Nile virus by Culex pipiens mosquitoes. PLoS Pathog (2008) 2.88
Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe. Emerg Infect Dis (2006) 2.76
CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. J Infect Dis (2010) 2.72
Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol (2004) 2.71
Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A. Virology (1998) 2.68
Introduction of West Nile virus in the Middle East by migrating white storks. Emerg Infect Dis (2002) 2.63
Persistent shedding of West Nile virus in urine of experimentally infected hamsters. Am J Trop Med Hyg (2005) 2.60
Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics (2006) 2.53
Surveillance for human West Nile virus disease - United States, 1999-2008. MMWR Surveill Summ (2010) 2.47
First field evidence for natural vertical transmission of West Nile virus in Culex univittatus complex mosquitoes from Rift Valley province, Kenya. Am J Trop Med Hyg (2000) 2.44
Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis (2003) 2.34
Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis (2001) 2.34
Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med (2005) 2.32
West Nile virus. Lancet Neurol (2007) 2.26
Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults. J Infect Dis (2011) 2.25
Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes. J Virol (2006) 2.20
West Nile fever outbreak, Israel, 2000: epidemiologic aspects. Emerg Infect Dis (2001) 2.15
Differential virulence of West Nile strains for American crows. Emerg Infect Dis (2004) 2.11
Community-acquired West Nile virus infection in solid-organ transplant recipients. Transplantation (2004) 2.11
The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex. J Virol (2010) 2.06
Immature dengue virus: a veiled pathogen? PLoS Pathog (2010) 2.04
Novel flavivirus or new lineage of West Nile virus, central Europe. Emerg Infect Dis (2005) 1.98
West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med (2005) 1.98
A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. J Infect Dis (2008) 1.95
Epidemiology of west nile in europe and in the mediterranean basin. Open Virol J (2010) 1.94
Possible West Nile virus transmission to an infant through breast-feeding--Michigan, 2002. MMWR Morb Mortal Wkly Rep (2002) 1.92
West nile virus RNA not detected in urine of 40 people tested 6 years after acute West Nile virus disease. J Infect Dis (2010) 1.88
Phylogeography of West Nile virus: from the cradle of evolution in Africa to Eurasia, Australia, and the Americas. J Virol (2010) 1.88
Vertical transmission of West Nile virus by Culex and Aedes species mosquitoes. Am J Trop Med Hyg (1993) 1.86
Laboratory-acquired West Nile virus infections--United States, 2002. MMWR Morb Mortal Wkly Rep (2002) 1.85
Ongoing outbreak of West Nile virus infections in humans in Greece, July-August 2010. Euro Surveill (2010) 1.82
West Nile virus isolates from India: evidence for a distinct genetic lineage. J Gen Virol (2007) 1.82
West Nile virus in the Americas. Med Clin North Am (2008) 1.78
The long-term outcomes of human West Nile virus infection. Clin Infect Dis (2007) 1.77
Persistent neuroinvasive West Nile virus infection in an immunocompromised patient. Clin Infect Dis (2006) 1.76
Detection of West Nile virus lineage 2 in mosquitoes during a human outbreak in Greece. Clin Microbiol Infect (2011) 1.75
West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction. J Virol (2008) 1.75
The zoonotic flaviviruses of southern, south-eastern and eastern Asia, and Australasia: the potential for emergent viruses. Zoonoses Public Health (2009) 1.67
West Nile virus and other zoonotic viruses in Russia: examples of emerging-reemerging situations. Arch Virol Suppl (2004) 1.63
West Nile in the Mediterranean basin: 1950-2000. Ann N Y Acad Sci (2001) 1.61
West Nile virus epidemic in horses, Tuscany region, Italy. Emerg Infect Dis (2002) 1.60
Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models. Antivir Chem Chemother (2004) 1.60
Changing patterns of West Nile virus transmission: altered vector competence and host susceptibility. Vet Res (2009) 1.59
Vertical transmission of West Nile Virus by three California Culex (Diptera: Culicidae) species. J Med Entomol (2003) 1.58
A comparison of methods of pathogen inactivation of FFP. Vox Sang (2011) 1.57
Phylogenetic relationships of southern African West Nile virus isolates. Emerg Infect Dis (2002) 1.55
Isolation of usutu virus in Germany. Am J Trop Med Hyg (2011) 1.55
Zoonotic mosquito-borne flaviviruses: worldwide presence of agents with proven pathogenicity and potential candidates of future emerging diseases. Vet Microbiol (2009) 1.54
Impact of extrinsic incubation temperature and virus exposure on vector competence of Culex pipiens quinquefasciatus Say (Diptera: Culicidae) for West Nile virus. Vector Borne Zoonotic Dis (2007) 1.53
Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells. J Infect Dis (2000) 1.52
Detection of West Nile virus lineages 1 and 2 by real-time PCR. J Virol Methods (2007) 1.49
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses. Vaccine (2009) 1.48
Manifestations of West Nile neuroinvasive disease. Rev Med Virol (2006) 1.45
Avian virulence and thermostable replication of the North American strain of West Nile virus. J Gen Virol (2006) 1.45
A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial. J Infect Dis (2011) 1.42
West Nile virus surveillance using sentinel birds. Ann N Y Acad Sci (2001) 1.42
Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target. Antiviral Res (2008) 1.41
Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles. J Virol (2010) 1.41
Ultrastructural study of West Nile virus pathogenesis in Culex pipiens quinquefasciatus (Diptera: Culicidae). J Med Entomol (2005) 1.39
Evidence of simultaneous circulation of West Nile and Usutu viruses in mosquitoes sampled in Emilia-Romagna region (Italy) in 2009. PLoS One (2010) 1.37
The flavivirus polymerase as a target for drug discovery. Antiviral Res (2008) 1.36
West Nile virus lineage 2 as a cause of zoonotic neurological disease in humans and horses in southern Africa. Vector Borne Zoonotic Dis (2010) 1.36
Putative new lineage of west nile virus, Spain. Emerg Infect Dis (2010) 1.35
Human case of autochthonous West Nile virus lineage 2 infection in Italy, September 2011. Euro Surveill (2011) 1.35
Outbreak of West Nile virus infection in humans, Romania, July to October 2010. Euro Surveill (2011) 1.30
West Nile virus in Italy: a further threat to blood safety, a further challenge to the blood system. Blood Transfus (2008) 1.29
Detection and molecular analysis of West Nile virus infections in birds of prey in the eastern part of Austria in 2008 and 2009. Vet Microbiol (2010) 1.27
West Nile virus infection of horses. Vet Res (2004) 1.26
West Nile fever characteristics among viremic persons identified through blood donor screening. J Infect Dis (2010) 1.26
Progress on the development of therapeutics against West Nile virus. Antiviral Res (2009) 1.26
Ongoing outbreak of West Nile virus infection in humans, Greece, July to August 2011. Euro Surveill (2011) 1.24
Lineage 2 west nile virus as cause of fatal neurologic disease in horses, South Africa. Emerg Infect Dis (2009) 1.24
West Nile fever in Israel 1999-2000: from geese to humans. Ann N Y Acad Sci (2001) 1.23
West Nile virus meningoencephalitis. Nat Clin Pract Neurol (2006) 1.22
NS1 protein secretion during the acute phase of West Nile virus infection. J Virol (2005) 1.22
West Nile virus transmission with human cases in Italy, August - September 2009. Euro Surveill (2009) 1.18
Differential effects of mutations in NS4B on West Nile virus replication and inhibition of interferon signaling. J Virol (2007) 1.17
Characterization of the functional requirements of West Nile virus membrane fusion. J Gen Virol (2009) 1.17
Geographic variation in vector competence for West Nile virus in the Culex pipiens (Diptera: Culicidae) complex in California. Vector Borne Zoonotic Dis (2007) 1.16
Evidence of enzootic circulation of West Nile virus (Nea Santa-Greece-2010, lineage 2), Greece, May to July 2011. Euro Surveill (2011) 1.16
Epidemiology of West Nile infection in Volgograd, Russia, in relation to climate change and mosquito (Diptera: Culicidae) bionomics. Parasitol Res (2008) 1.16
Emergence and establishment of Usutu virus infection in wild and captive avian species in and around Zurich, Switzerland--genomic and pathologic comparison to other central European outbreaks. Vet Microbiol (2010) 1.15
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis (2013) 7.83
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet (2003) 6.52
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature (2013) 6.39
Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg Infect Dis (2013) 5.25
Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol (2013) 4.98
Bats host major mammalian paramyxoviruses. Nat Commun (2012) 4.15
Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio (2012) 3.96
Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C. Gastroenterology (2002) 3.96
Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis (2014) 3.74
Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg Infect Dis (2013) 3.61
Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis (2014) 3.25
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol (2004) 3.07
Detection and prevalence patterns of group I coronaviruses in bats, northern Germany. Emerg Infect Dis (2008) 3.00
Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus. Emerg Infect Dis (2009) 2.86
Circulation of group 2 coronaviruses in a bat species common to urban areas in Western Europe. Vector Borne Zoonotic Dis (2010) 2.65
Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe. Transfusion (2002) 2.53
Distant relatives of severe acute respiratory syndrome coronavirus and close relatives of human coronavirus 229E in bats, Ghana. Emerg Infect Dis (2009) 2.52
Circulation of 3 lineages of a novel Saffold cardiovirus in humans. Emerg Infect Dis (2008) 2.35
Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006. Emerg Infect Dis (2008) 2.29
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28
Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus. Transfusion (2008) 2.27
Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. J Infect Dis (2007) 2.22
Novel human parvovirus 4 genotype 3 in infants, Ghana. Emerg Infect Dis (2010) 2.19
Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. MBio (2013) 2.17
RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene. Trans R Soc Trop Med Hyg (2007) 2.10
The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol (2013) 2.10
Henipavirus RNA in African bats. PLoS One (2009) 2.10
High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome coronavirus in Hajj pilgrims returning to Ghana, 2013. Trop Med Int Health (2015) 2.09
Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012. J Infect Dis (2013) 2.06
Amplification of emerging viruses in a bat colony. Emerg Infect Dis (2011) 1.98
Chikungunya fever in travelers: clinical presentation and course. Clin Infect Dis (2007) 1.93
Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis (2003) 1.91
Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013. Emerg Infect Dis (2014) 1.89
Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray. J Clin Microbiol (2007) 1.89
Prevalence, types, and RNA concentrations of human parechoviruses, including a sixth parechovirus type, in stool samples from patients with acute enteritis. J Clin Microbiol (2007) 1.79
Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs (2005) 1.78
Spectrum of viruses and atypical bacteria in intercontinental air travelers with symptoms of acute respiratory infection. J Infect Dis (2007) 1.75
Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus. J Clin Microbiol (2004) 1.74
Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect (2002) 1.71
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997. Emerg Infect Dis (2014) 1.71
Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma. Blood (2005) 1.69
Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family Hepeviridae. J Virol (2012) 1.69
Seroprevalence and incidence of hepatitis E virus infection in German blood donors. Transfusion (2013) 1.66
Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions. Transfusion (2009) 1.64
Crimean-Congo hemorrhagic fever in Kosovo. J Clin Microbiol (2002) 1.64
Diagnosing schistosomiasis by detection of cell-free parasite DNA in human plasma. PLoS Negl Trop Dis (2009) 1.63
Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis (2006) 1.62
Hantavirus in bat, Sierra Leone. Emerg Infect Dis (2012) 1.60
Failure to detect Borna disease virus antigen and RNA in human blood. J Clin Virol (2006) 1.59
Evidence for novel hepaciviruses in rodents. PLoS Pathog (2013) 1.54
Coronavirus antibodies in African bat species. Emerg Infect Dis (2007) 1.54
Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg Infect Dis (2007) 1.53
A novel diagnostic target in the hepatitis C virus genome. PLoS Med (2009) 1.52
NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions. Transfusion (2004) 1.49
HIV-2EU: supporting standardized HIV-2 drug resistance interpretation in Europe. Clin Infect Dis (2013) 1.49
The network of psychological variables in patients with diabetes and their importance for quality of life and metabolic control. Diabetes Care (2002) 1.46
Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011. PLoS One (2011) 1.45
Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA. J Clin Microbiol (2010) 1.45
A multi-centre collaborative study on the potency estimation of ReFacto. Thromb Haemost (2003) 1.45
Detection of antibiotic-resistant bacteria and their resistance genes in wastewater, surface water, and drinking water biofilms. FEMS Microbiol Ecol (2003) 1.44
Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol (2011) 1.44
Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity. J Clin Microbiol (2002) 1.44
Replicative Capacity of MERS Coronavirus in Livestock Cell Lines. Emerg Infect Dis (2014) 1.42
[When viruses jump over species boundaries. Are dogs and cats to be permitted into bed?]. MMW Fortschr Med (2003) 1.41
Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis. J Neurol Neurosurg Psychiatry (2012) 1.41
Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol (2011) 1.40
Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J Virol (2013) 1.40
Xenotropic murine leukemia virus-related gammaretrovirus in respiratory tract. Emerg Infect Dis (2010) 1.40
Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil. J Clin Microbiol (2007) 1.37
Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol (2011) 1.37
Confirmation of putative HIV-1 group P in Cameroon. J Virol (2010) 1.36
Novel human parechovirus from Brazil. Emerg Infect Dis (2009) 1.36
MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever. Emerg Infect Dis (2006) 1.35
Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium. J Clin Virol (2005) 1.33
First international quality assurance study on the rapid detection of viral agents of bioterrorism. J Clin Microbiol (2004) 1.33
Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med (2014) 1.30
Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J Virol (2004) 1.30
Lassa fever, Nigeria, 2003 and 2004. Emerg Infect Dis (2005) 1.28
Detection, differentiation, and quantitation of pathogenic leishmania organisms by a fluorescence resonance energy transfer-based real-time PCR assay. J Clin Microbiol (2003) 1.28
Inactivation of parvovirus B19 during pasteurization of human serum albumin. Transfusion (2002) 1.27
Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets. Transfusion (2007) 1.27
Characterization of a novel betacoronavirus related to middle East respiratory syndrome coronavirus in European hedgehogs. J Virol (2013) 1.26
Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. J Virol Methods (2008) 1.26
Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles? Acta Neuropathol (2014) 1.24
Type I interferon reaction to viral infection in interferon-competent, immortalized cell lines from the African fruit bat Eidolon helvum. PLoS One (2011) 1.23
An insect nidovirus emerging from a primary tropical rainforest. MBio (2011) 1.23
Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg Infect Dis (2007) 1.20
Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion (2002) 1.19
Two novel parvoviruses in frugivorous New and Old World bats. PLoS One (2011) 1.19
Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes. Proc Natl Acad Sci U S A (2013) 1.19
Quality and Safety in Blood Supply in 2010. Transfus Med Hemother (2010) 1.17
Detection and quantification of Mycobacterium leprae in tissue samples by real-time PCR. Med Microbiol Immunol (2003) 1.17
Discovery of a unique novel clade of mosquito-associated bunyaviruses. J Virol (2013) 1.17
Virus discovery and recent insights into virus diversity in arthropods. Curr Opin Microbiol (2013) 1.16
Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol (2005) 1.15
Sensitivity of HCV RNA and HIV RNA blood screening assays. Transfusion (2002) 1.15
The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog (2011) 1.14